Siegel RL, Miller KD, Jemal A (January 2020). “Cancer statistics, 2020”. 《CA: A Cancer Journal for Clinicians》 70 (1): 7–30. doi:10.3322/caac.21590. PMID31912902.
Gillison ML, Castellsagué X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, 외. (February 2014). “Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix”. 《International Journal of Cancer》 134 (3): 497–507. doi:10.1002/ijc.28201. PMID23568556. S2CID37877664.
Syn NL, Teng MW, Mok TS, Soo RA (December 2017). “De-novo and acquired resistance to immune checkpoint targeting”. 《The Lancet. Oncology》 18 (12): e731–e741. doi:10.1016/s1470-2045(17)30607-1. PMID29208439.
Siegel RL, Miller KD, Jemal A (January 2020). “Cancer statistics, 2020”. 《CA: A Cancer Journal for Clinicians》 70 (1): 7–30. doi:10.3322/caac.21590. PMID31912902.
Gillison ML, Castellsagué X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, 외. (February 2014). “Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix”. 《International Journal of Cancer》 134 (3): 497–507. doi:10.1002/ijc.28201. PMID23568556. S2CID37877664.
Syn NL, Teng MW, Mok TS, Soo RA (December 2017). “De-novo and acquired resistance to immune checkpoint targeting”. 《The Lancet. Oncology》 18 (12): e731–e741. doi:10.1016/s1470-2045(17)30607-1. PMID29208439.
Gillison ML, Castellsagué X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, 외. (February 2014). “Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix”. 《International Journal of Cancer》 134 (3): 497–507. doi:10.1002/ijc.28201. PMID23568556. S2CID37877664.